Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Levodopa/adverse effects"'
Autor:
Jan Bert Gramsbergen, Egon Stenager, Nils J. Færgeman, Niels H. H. Heegaard, Andreas Dammann Andersen, Michael Binzer, Jesper F. Havelund, Morten Blaabjerg
Publikováno v:
Havelund, J F, Dammann Andersen, A, Binzer, M, Blaabjerg, M, Heegaard, N H H, Stenager, E, Faergeman, N J & Gramsbergen, J B 2017, ' Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia ', Journal of Neurochemistry, vol. 142, no. 5, pp. 756–766 . https://doi.org/10.1111/jnc.14104
L-3,4-Dihydroxyphenylalanine (L-DOPA) is the most effective drug in the symptomatic treatment of Parkinson's disease, but chronic use is associated with L-DOPA-induced dyskinesia in more than half the patients after 10 years of treatment. L-DOPA trea
Autor:
Jean-Louis Quesada, Pierre Pollak, Emmanuelle Schmitt, Paul Krack, Anna Castrioto, Patrick Mertens, Emmanuel Broussolle, Valérie Fraix, Stephan Chabardes, Eugénie Lhommée, Hélène Klinger, Stéphane Thobois, Andrea Kistner
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 84, No 1 (2013) pp. 18-22
Background Levodopa therapy in Parkinson9s disease (PD) is associated with non-motor complications resulting from sensitisation of the ventral striatum system. Recent studies showed an improvement in non-motor complications in PD patients with subtha
Publikováno v:
European Journal of Neurology, Vol. 14, No 10 (2007) pp. 1124-8
Levodopa (LD)-induced dyskinesia (LID), one of the most common motor complications in advanced Parkinson's disease (PD), involve mostly the limbs, trunk and head, but unusual locations have been reported including respiratory muscles, the face and th
Publikováno v:
Behavioural Brain Research. 170:337-341
Chronic daily administration of 6.25mg/kg of levodopa in unilaterally 6-OHDA lesioned rats did not induce any observable behavioral effects for the first 12.5+/-2.5 days. Thereafter, levodopa administration induced abnormal involuntary movements (AIM
Publikováno v:
Movement Disorders, Vol. 17 Suppl 3 (2002) pp. S188-97
The postoperative neurologic management of patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson' s disease is a complex dynamic process that involves a progressive increase in stimulation intensity and a parallel
AIM: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established therapy for patients with Parkinson's disease (PD) associated with motor complications of long term L-dopa treatment. MATERIAL AND METHODS: Here we report two cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::61be4747b9a343c873338e4c94408cf6
Autor:
Sônia M. C. Azevedo-silva, Maria Sheila Guimarães Rocha, Vanderci Borges, Luiz Augusto Franco de Andrade, Henrique Ballalai Ferraz
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 53, Iss 2, Pp 245-251 (1995)
Arquivos de Neuro-Psiquiatria v.53 n.2 1995
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 53, Issue: 2, Pages: 245-251, Published: JUN 1995
Arquivos de Neuro-Psiquiatria v.53 n.2 1995
Arquivos de neuro-psiquiatria
Academia Brasileira de Neurologia
instacron:ABNEURO
Arquivos de Neuro-Psiquiatria, Volume: 53, Issue: 2, Pages: 245-251, Published: JUN 1995
As flutuações motoras (FM) decorrentes do uso prolongado de levodopa são uma das principais complicações do tratamento da doença de Parkinson (DP). A utilização da apomorfina, um potente agonista de receptores dopaminérgicos, associada ao do
Autor:
Valérie Fraix, Eugénie Lhommée, Bettina Debû, Pierre Pollak, Stephan Chabardes, Paul Krack, Alim-Louis Benabid, Claire Ardouin, Eric Seigneuret, Murielle Ursulla Ferraye
Publikováno v:
European Neurology, Vol. 69, No 5 (2013) pp. 281-288
We examined executive functioning in patients with Parkinson's disease exhibiting, or not, levodopa-resistant freezing of gait (L-FOG). 38 advanced-stage patients with L-FOG were identified in a consecutive series of 400 patients. They were matched w
Autor:
Magaly Aya Kombo, Valérie Fraix, Eugénie Lhommée, Eric Seigneuret, Stephan Chabardes, Sebastien Carnicella, Jean-Louis Quesada, Stéphane Thobois, Paul Krack, Jean-Luc Bosson, Patrick Mertens, Alim-Louis Benabid, Emmanuelle Schmitt, Hélène Klinger, Jing Xie, Andrea Kistner, Amélie Bichon, Claire Ardouin, Emmanuel Broussolle, Gustavo Polo, Pierre Pollak
Publikováno v:
Brain, Vol. 135, No Pt 5 (2012) pp. 1463-77
Addictions to dopaminergic drugs or to pleasant behaviours are frequent and potentially devastating neuropsychiatric disorders observed in Parkinson's disease. They encompass impulse control disorders, punding and dopamine dysregulation syndrome. A r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::213e54e2aa0aeb754c890e333fd7e708
https://archive-ouverte.unige.ch/unige:32810
https://archive-ouverte.unige.ch/unige:32810
Publikováno v:
Clinical Interventions In Aging, vol. 5, pp. 229-238
After more than 40 years of clinical use, levodopa (LD) remains the gold standard of symptomatic efficacy in the drug treatment of Parkinson's disease (PD). Compared with other available dopaminergic therapies, dopamine replacement with LD is associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::62b45aa93c978945c7c32c37a0232e8f
https://serval.unil.ch/resource/serval:BIB_312BEA16C2AD.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_312BEA16C2AD.P001/REF.pdf